Our objectives are as follows:
- Increasing engagement with industry, business development and sustainability of both the Hub and in promoting investments into UK based mental health research generally
- The development of approaches to identify drug targets and develop more effective pharmacological interventions and/or better understand why some drugs work better for some people than others.
Impact and outcomes
New funding £4.29M from the Wellcome Trust.
Engaging with industry can lead to the development of new ideas and approaches, to novel collaborations and ultimately to future investment in the field of mental health.
We plan to further develop the plans and ideas that led to this award in pursuit of identifying new and more effective drug for psychiatric disorders using genomic approaches to drug target identification and validation.